Diagnostic lab focused on detection and characterization of allergen sensitivity through antibody and profile testing.
What Makes Us Unique
- Specific IgE (sIgE) blood antibody testing
- Multiple regional, pediatric, and respiratory allergy profiles
- Comprehensive approach to initial allergy evaluation
Allergen Antibody Testing
Tests Associated:
1. Specific IgE (sIgE) ImmunoCAP panel
2. Comprehensive IgE allergy listing
Profile Testing
Tests Associated:
1. Profile tests for food, inhalants, and pediatric allergens
2. Respiratory profiles — regional specific
3. Screening panels for common allergens
Integrated diagnostic and prognostic solutions in cardiovascular disease, using genetics, biomarkers, and consultative interpretation.
What Makes Us Unique
- Targeted genomic panels for inherited cardiac disorders
- Novel biomarker evaluation (lipids, ceramides, ST2, etc.)
- Direct access to clinical experts in acute and preventive care
Cardiovascular Genetics
Tests Associated:
1. Multigene NGS panel for arrhythmias, cardiomyopathy, congenital heart disease
2. Family cascade panels
Pathology and Biomarker Testing
Tests Associated:
1. MI-Heart Ceramides assay
2. Lp-PLA2 and soluble ST2 biomarker panels
3. Postmortem cardiac genetic panel
Risk Assessment and Remote Monitoring
Tests Associated:
1. Comprehensive panel for risk stratification
2. Remote cardiac monitoring support
Comprehensive diagnostic menu for adrenal, thyroid, growth, and hormone disorders, using optimized reference ranges and methods.
What Makes Us Unique
- Collaborative care model validating new testing and methodology
- Continuous innovation using machine learning and reference data
- Dedicated methodology for pediatric and rare endocrine conditions
Hormone and Growth Disorders
Tests Associated:
1. Comprehensive steroid hormone panel
2. Adrenal and thyroid rare disease gene panel
3. Growth disorder genetic and biochemical panel
Adrenal Tumors
Tests Associated:
1. Urinary Steroid Profile assay
2. Tissue-based enzyme activity
Diabetes and Metabolic
Tests Associated:
1. Type 1 and 2 diabetes panel
2. Metabolic syndrome risk assessment
Diagnostic testing and innovation for inherited and acquired immune conditions; advances in autoimmunity, allergy, and rare syndromes.
What Makes Us Unique
- Latest research and clinical trials inform assay development
- Evidence-based monitoring and discovery for immune disorders
- Direct access to multidisciplinary expert team
Allergen and Autoimmune Testing
Tests Associated:
1. Autoimmune neurological disorder antibody panel
2. Hereditary immunologic disorder panels
3. Inflammatory bowel disease immune markers
4. Mast cell activation syndrome panel
Rheumatic Disease
Tests Associated:
1. Comprehensive lupus panel
2. Myositis antibody panel
Innovative diagnostics for rheumatic diseases—lupus, myositis, and complex multisystem autoimmune conditions.
What Makes Us Unique
- Novel collaborations for leading-edge assay development
- Evidence-based approach for disease characterization and therapy monitoring
- Subspecialty consultative guidance
Lupus
Tests Associated:
1. Lupus advanced biomarker panel
2. Progentec lupus activity and flare risk panel
Myositis
Tests Associated:
1. Comprehensive myositis antibody panel
2. Molecular characterization panel
CLINICALLY ACTIONABLE TESTING DEVELOPED BY EXPERTS
Laboratories offers preeclampsia, prenatal, breast and gynecological cancer, and other testing to support women’s health. Our broad suite of testing has been developed in collaboration with clinical leaders in a variety of women’s health specialties to provide accurate, actionable results.
What Makes Us Unique
- Developed in collaboration with clinical leaders in women’s health
- Accurate, actionable results
- Suite includes preeclampsia, prenatal, breast and gynecological cancer, and other testing
Breast and Gynecological Cancer
Tests Associated:
1. Breast cancer panel (NGS, halves turnaround time: new breast cancer panel provides rapid results to guide critical decisions about treatment and screening.)
2. Gynecological NGS panels (“focused assessments of gynecological cancers… bridging the gap between single gene assays and large cancer panels, to inform prognosis and treatment.”)
3. Hereditary panels (BRCA1/2, PALB2, etc. referenced via hereditary cancer menu)
Preeclampsia
Tests Associated:
1. Preeclampsia-specific test (“used to stratify patients into low or high-risk categories for developing preeclampsia with severe features”)
2. Assay guides clinical management including hospitalization, monitoring, more frequent checkups, or early delivery.
Prenatal
Tests Associated:
1. Noninvasive prenatal screening (referenced via Genetics/Prenatal link: “NGS, expanded carrier and aneuploidy panels”)
Other Featured News/Tests
1. Second-tier assay for MPS I Newborn Screening (alpha-L-iduronidase for mucopolysaccharidosis type I, improves specificity, reduces false positives)